Related Experiment Video
Updated: Apr 1, 2026

A Chromatin Immunoprecipitation Assay to Identify Novel NFAT2 Target Genes in Chronic Lymphocytic Leukemia
Published on: December 4, 2018
[Nuclear factor-κB pathway mediates the effects of CD137 signaling on NFATc1 expression in mice vascular smooth
Yunjie Yin1, Jinchuan Yan2, Zhongqun Wang1
1Department of Cardiology, Affiliated Hospital of Jiangsu University, Zhenjiang 212001, China.
Objective:
To observe whether CD137 signaling could affect the nuclear factor of activated T cells c1 (NFATc1) expression through nuclear factor-κB (NF-κB) pathway in mice aortic vascular smooth muscle cells (VSMCs).
Methods:
Adherence methods for tissues explants were used for primary culture of mouse aortic VSMCs. The mRNA expression of CD137 and NFATc1 was detected by real-time quantitative PCR (RT-qPCR). The VSMCs protein expression of IκB-α, NF-κB p65, phospo-p65 and NFATc1 was determined by Western blot. The level of CD137 was measured by Flow Cytometry (FCM).
Results:
(1) The mRNA and protein expression of CD137 in VSMCs was significantly upregulated at 24 h after co-culture with TNF-α (10 ng/ml, all P < 0.05). (2) Compared with the control group, the level of p-NF-κB p65 in cytoplasm and nucleus was significantly increased (8.34 ± 0.28 vs. 1, P < 0.05, and 2.64 ± 0.42 vs. 1, P < 0.05) while the level of IκB-α was reduced (1 vs. 2.70 ± 0.28, P < 0.05) after co-treatment with agonist-CD137 mAb, above effects were partly blocked by adding specific NF-κB inhibitor PDTC (30 µmol/L: 1.15 ± 0.14 vs. 8.34 ± 0.28, P < 0.05, and 2.09 ± 0.12 vs. 2.64 ± 0.42, P < 0.05, and 1.78 ± 0.74 vs. 1, P < 0.05). (3) The mRNA (2.07 ± 0.09 vs. 1, P < 0.05) and protein (1.75 ± 0.07 vs. 1, P < 0.05) expression of NFATc1 was significantly upregulated by agonist CD137mAb compared with the control group, and these effects could be reversed by PDTC (1.15 ± 0.07 vs. 2.07 ± 0.09, P < 0.05, and 0.90 ± 0.11 vs. 1.75 ± 0.07, P < 0.05).
Conclusion:
CD137 signaling could affect the NFATc1expression in VSMCs through NF-kappaB pathway.
Insights
CD137 signaling activates the nuclear factor-kappaB (NF-κB) pathway, leading to increased nuclear factor of activated T cells c1 (NFATc1) expression in mouse aortic vascular smooth muscle cells (VSMCs). This pathway is crucial for regulating NFATc1 in VSMCs.
Area of Science:
- Immunology
- Cell Biology
- Vascular Biology
Background:
- Vascular smooth muscle cells (VSMCs) play a critical role in vascular homeostasis and disease.
- CD137 is a co-stimulatory molecule known for its role in immune responses.
- The involvement of CD137 signaling in VSMCs and its downstream pathways remains incompletely understood.
Purpose of the Study:
- To investigate the effect of CD137 signaling on nuclear factor of activated T cells c1 (NFATc1) expression in mouse aortic VSMCs.
- To elucidate the role of the nuclear factor-kappaB (NF-κB) pathway in mediating CD137-induced NFATc1 regulation.
Main Methods:
- Primary culture of mouse aortic VSMCs using tissue explant adherence methods.
- Detection of mRNA expression for CD137 and NFATc1 via real-time quantitative PCR (RT-qPCR).
- Assessment of protein expression (IκB-α, NF-κB p65, phospho-p65, NFATc1) using Western blot and CD137 levels by Flow Cytometry (FCM).
Main Results:
- CD137 expression was significantly upregulated in VSMCs upon TNF-α co-culture.
- CD137 signaling activated the NF-κB pathway, evidenced by increased phospho-p65 and decreased IκB-α, an effect reversible by an NF-κB inhibitor (PDTC).
- NFATc1 mRNA and protein expression were significantly upregulated by CD137 signaling, with effects reversed by PDTC.
Conclusions:
- CD137 signaling modulates NFATc1 expression in VSMCs.
- The NF-κB pathway is a key mediator of CD137-induced NFATc1 regulation in VSMCs.
- These findings highlight a novel role for CD137 signaling in vascular smooth muscle cells.
More Related Videos
Related Concept Videos
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
NF-kB-dependent Signaling Pathway
TGF - β Signaling Pathway
MAPK Signaling Cascades
Regulation of Nuclear Protein Sorting
Co-activators and Co-repressors

